| Quantum Genomics gets approval from the Patients’ Protection Committee. |
|
| QGC |
05-01-2012 |
Read More |
| Quantum Genomics a reçu l’avis favorable du Comité de Protection des Personnes. |
|
| QGC |
05-01-2012 |
Read More |
| QUANTUM GENOMICS (NYSE EURONEXT PARIS: MLQGC) ANNOUNCED TODAY POSITIVE SCIENTIFIC RESULTS WITH ITS PRODUCT QGC001 |
|
| QGC |
01-04-2011 |
Read More |
| Quantum Genomics (NYSE Euronext Paris: MLQGC) announced today that EUR 1.4 million in funding has been granted by the National Research Agency (ANR) for a collaborative research project named BAPAI |
|
| QGC |
01-02-2011 |
Read More |
| Quantum Genomics enters the NYSE-Euronext Market (MLQGC) |
|
| QGC |
28-07-2009 |
Read More |
| Quantum Genomics gets 1 Million $ (740 K€) from Oseo to finance the regulatory preclinical development of QGC 001. |
|
| QGC |
02-04-2009 |
Read More |
| Quantum Genomics Corp signs strategic agreement with PCAS to make first batch of hypertension drug candidate |
|
| QGC |
08-07-2008 |
Read More |
| Quantum Genomics Corp partners with Inserm in stroke and cardiac ischemia drug development |
|
| QGC |
24-01-2008 |
Read More |
| Quantum Genomics widens net with acquisition of Eurobiobiz SAS |
|
| QGC |
29-10-2007 |
Read More |
| Quantum Genomics Corp partners with Inserm and CNRS in hypertension drug development |
|
| QGC |
28-06-2007 |
Read More |
| Quantum Genomics Corp. appoints Fabrice Balavoine Head of Research |
|
| QGC |
18-12-2006 |
Read More |
| QGC names Jean-Pierre Riffaud Head of Preclinical Development |
|
| QGC |
18-10-2006 |
Read More |
| Quantum Genomics Corp opens European HQ in Paris region |
|
| QGC |
03-07-2006 |
Read More |
| QGC names Lionel SEGARD CEO |
|
| QGC |
06-06-2006 |
Read More |